Industry seeks to expand investments in manufacturing, report finds

By Zachary Brennan

- Last updated on GMT

Related tags Raw materials Process analytical technology Better Manufacturing Big pharma

Industry seeks to expand investments in manufacturing, report finds
As pharma manufacturers look to cut costs and increase quality, over 70% of industry executives interviewed for a recent CPhI report say they are actively investing in manufacturing techniques and technologies to achieve these goals.

Improving product quality and reducing manufacturing costs were seen as the top goals for the future, the report​ found.

We are seeing a desire by industry to increasingly adopt tools and methods to quantify the value and quality of their work and, consequently, adapt their manufacturing techniques to enable continuous improvement and improve product quality​,” CPhI said in their report on a survey of Big Pharma, API companies, CMOs and other manufacturers.

Quality by Design and Process Analytical Technology are quickly becoming tools companies are using for continuous improvements, as 16% and 11% of respondents said they were seeking these tools out, respectively. “We may see a growing uptake of 6 sigma and Lean which have both been shown to be effective in waste reduction- a vital objective for manufacturers​,” CPhI says.

Girish Malhotra, president of Epcot International, noted, “Process improvements could save billions in cost, lowering the price of drugs and opening up newer markets to pharma. This has to be the short and long term goal. Process improvements made in existing approved products have to be approved by the regulatory bodies​.”

Raw Materials

Despite the need for higher quality in manufacturing, 11% of respondents said that they do not test all incoming raw materials sourced to their facilities, though almost half said they connect with suppliers weekly.

Of the 89% that are testing raw materials sourced to their facilities, compendial testing was an unrivalled method of choice (81%) and one that “is likely to remain the principal approach over the next few years​,” as other methods including gas chromatography, liquid chromatography and mass spectrometry are being used by just 15% of the industry to test sourced raw materials, CPhI found.

Responses also suggest that outsourcing is becoming a more important strategy in manufacturing, as 41% said that they are outsourcing more of their manufacturing to other organizations.

Malhotra concluded, “The current manufacturing model is also an obstacle. Regulatory bodies cannot drive excellence in companies. It is my hope that the industry will review the model and drive itself to excellence. Unless this happens regulatory bodies through additional regulations will force the industry to drive to excellence. This will only increase costs​.”

Related news

Show more

Related products

show more

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us


View more